We are thrilled to see DNlite's predictive technology increasingly adopted by primary care clinics across Taiwan, delivering true precision medicine to patients with diabetes.
Recently, Dr. Hung-Lin Chen, President of the Taiwan Primary Care Diabetes Association, was featured in an exclusive interview with Hello Yishi (a leading health media platform) to discuss the paradigm shift in combating Chronic Kidney Disease (CKD).
In the interview, Dr. Chen highlighted a critical message: "We must transition from passive treatment to proactive prediction." He emphasized how innovative biomarkers like DNlite empower primary care physicians to overcome the diagnostic blind spots of traditional tests, identifying high-risk patients long before irreversible structural damage occurs.
????️ Watch the highlight reel (Mandarin) to see how DNlite is changing the game in primary care:
* Facebook:https://www.facebook.com/share/1C5E1mJbWN/
* Youtube:https://www.youtube.com/watch?v=26xnJFSDXpA
* Eventsite:https://helloyishi-event.com/event.php?id=10
Related News
Boditech Med (South Korea) announces on its official website the signing of a licensing MOU with Bio Preventive Medicine.
Boditech Med (South Korea) announces on its official website the signing of a licensing MOU with Bio Preventive Medicine.
2024/05/30
Press
BPM’s Cross-Ethnic DKD Clinical Study Published in Top-Tier American Journal of Nephrology
Paving the Way for US Market Entry
2023/10/13
Press
BPM Signs Licensing MOU with South Korea’s Boditech Med to Integrate DNlite-IVD103 into POCT Platforms
BPM Signs Licensing MOU with South Korea’s Boditech Med to Integrate DNlite-IVD103 into POCT Platforms
2024/05/09
Press